| 000 | 01135 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250512213532.0 | ||
| 264 | 0 | _c19840622 | |
| 008 | 198406s 0 0 eng d | ||
| 022 | _a0065-1427 | ||
| 024 | 7 |
_a10.1111/j.1600-0404.1983.tb01524.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aStern, G M | |
| 245 | 0 | 0 |
_aClinical and pharmacological problems of deprenyl (selegiline) treatment in Parkinson's disease. _h[electronic resource] |
| 260 |
_bActa neurologica Scandinavica. Supplementum _c1983 |
||
| 300 |
_a113-6 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAmphetamine _xurine |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aHydrogen-Ion Concentration |
| 650 | 0 | 4 |
_aMethamphetamine _xurine |
| 650 | 0 | 4 |
_aParkinson Disease _xdrug therapy |
| 650 | 0 | 4 |
_aPhenethylamines _xtherapeutic use |
| 650 | 0 | 4 |
_aSelegiline _xtherapeutic use |
| 700 | 1 | _aLees, A J | |
| 700 | 1 | _aHardie, R J | |
| 700 | 1 | _aSandler, M | |
| 773 | 0 |
_tActa neurologica Scandinavica. Supplementum _gvol. 95 _gp. 113-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1600-0404.1983.tb01524.x _zAvailable from publisher's website |
| 999 |
_c6428027 _d6428027 |
||